What Myocardial Bridging on Angiogram Means
Myocardial bridging on angiogram means that a segment of an epicardial coronary artery runs underneath (tunnels through) the heart muscle instead of staying on the surface, appearing as characteristic systolic compression or "milking" of the artery during the cardiac cycle. 1, 2
Anatomical Definition
Myocardial bridging consists of muscle fiber bundles overlying an epicardial coronary artery for a variable distance 1. The muscle overlying the artery is termed the myocardial bridge, and the segment running through the myocardium is called the tunneled artery 3. The left anterior descending artery is affected in almost all cases 1.
Angiographic Appearance
The typical angiographic presentation is systolic compression of the artery during the cardiac cycle 1. This creates the characteristic "milking effect" where the vessel appears to be squeezed during systole 4. The vessel shows narrowing during systole with delayed and incomplete diameter gain during mid to late diastole 1.
Prevalence Discrepancy
There is a striking difference between angiographic and pathological detection:
- Angiography detects myocardial bridging in only 0.5-4.5% of cases 1
- Pathological studies find it in 15-85% of cases 1
- Coronary CT angiography (CCTA) detects it more frequently than invasive angiography (7.9% vs 2.1%) 5
This discrepancy occurs because many bridges are too superficial or short to cause visible systolic compression on angiography.
Clinical Significance: Usually Benign but Potentially Serious
Although most myocardial bridges are thought to be innocent, they may in some cases cause myocardial ischemia, myocardial infarction, malignant ventricular arrhythmias, atrioventricular block, and sudden cardiac death 1. The long-term prognosis of isolated myocardial bridges appears to be excellent, but exceptions exist 1.
High-Risk Features
Pathological studies suggest that vessels with:
- Tunneled length that is long
- Depth >3 mm beneath the epicardium
Create the greatest vulnerability for cardiac events 2.
Myocardial bridging occurs in 30-50% of patients with hypertrophic cardiomyopathy and has been suggested as a possible cause of sudden cardiac death in these patients 1, 6.
Mechanisms of Ischemia
The pathophysiology involves:
- Systolic compression of the tunneled segment (primary mechanism)
- Diastolic flow abnormalities with delayed vessel diameter recovery 1, 7
- Atherosclerotic lesions proximal to the bridge (the segment before the bridge is more susceptible to atherosclerosis due to hemodynamic disturbances) 7, 4
- Vasomotor disorders and microvascular dysfunction 4
- Persistence of compression into diastole when coronary blood flow primarily occurs 6
Functional Assessment Required
Identification of the presence and evaluation of the severity of myocardial bridges is of clinical importance 1. For evaluating hemodynamic significance, use:
- ECG exercise test
- Dobutamine stress echocardiography
- Myocardial perfusion scintigraphy
- Intracoronary Doppler flow velocity measurement (in selected cases) 1
Management Approach
For Asymptomatic or Mildly Symptomatic Patients:
Patients usually improve with beta-blockers 1. This is first-line medical therapy.
Critical caveat: Nitrates increase the angiographic systolic narrowing and can lead to worsening of symptoms 1. Avoid nitrates in myocardial bridging.
For Athletes:
It is reasonable for athletes with myocardial bridging and no evidence of myocardial ischemia during adequate stress testing to participate in all competitive sports 2.
It is reasonable to restrict athletes with myocardial bridging of an epicardial coronary artery and objective evidence of myocardial ischemia or prior myocardial infarction to sports with low to moderate dynamic and low to moderate static demands 2.
For Refractory Symptomatic Patients:
Medical treatment with beta-blockers, surgery, angioplasty, or stenting may be therapeutic alternatives. In refractory patients, surgery (myotomy and/or coronary bypass), angioplasty, or stenting can be considered 1.
For athletes who have undergone surgical resection of the myocardial bridge or stenting, restrict to low-intensity sports for 6 months after the procedure. If no subsequent evidence of ischemia, they may participate in all competitive sports 2.
Contemporary Understanding
The 2024 ESC guidelines recognize myocardial bridging as one of the structural abnormalities at the macrovascular level that may lead to transient myocardial ischemia in chronic coronary syndromes 8. It represents a congenital anatomical variant that can contribute to ischemia with non-obstructive coronary arteries (INOCA) 8, 9.